Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 204Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 15Nexium

02 1Vimovo

PharmaCompass

01

Brand Name : Nexium

Esomeprazole

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : 717

2019 Revenue in Millions : 729

Growth (%) : -2

blank

02

Brand Name : Nexium

Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole Magnesium

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2020 Revenue in Millions : 1,492

2019 Revenue in Millions : 1,483

Growth (%) : 1

blank

03

Brand Name : Nexium

Esomeprazole

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2021 Revenue in Millions : 478

2020 Revenue in Millions : 713

Growth (%) : -28

blank

04

Brand Name : Nexium

Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole Magnesium

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2021 Revenue in Millions : 1,326

2020 Revenue in Millions : 1,492

Growth (%) : -11

blank

05

Brand Name : Nexium

Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole Magnesium

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2022 Revenue in Millions : 1,285

2021 Revenue in Millions : 1,326

Growth (%) : -3

blank

06

Brand Name : Nexium

Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole Magnesium

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2023 Revenue in Millions : 945

2022 Revenue in Millions : 1,285

Growth (%) : -26

blank

07

Brand Name : Nexium

Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole Magnesium

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2015 Revenue in Millions : 3,655

2014 Revenue in Millions : 2,496

Growth (%) : -32%

blank

08

Brand Name : Vimovo

Naproxen + Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

09

Brand Name : Nexium

Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole Magnesium

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 1,952

2016 Revenue in Millions : 2,032

Growth (%) : -4

blank

10

Brand Name : Nexium

Esomeprazole Magnesium

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Nexium

arrow
BioFlorida Conference
Not Confirmed

Esomeprazole Magnesium

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2014 Revenue in Millions : -5.60%

2013 Revenue in Millions :

Growth (%) :

blank